A Safety Study of Rituximab Plus MTX Injected Into the Cerebrospinal Fluid in the Treatment of Brain Lymphoma

NCT00221325 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Central Nervous System Lymphoma
Intraocular Lymphoma

Interventions

DRUG: Intraventricular Rituximab Plus MTX

Sponsor

University of California, San Francisco